Carlson H E, Sowers J R, Rand R W
Metabolism. 1977 Jul;26(7):801-5. doi: 10.1016/0026-0495(77)90068-3.
Serum growth hormone (GH) responses to thyrotropin-releasing hormone (TRH) were evaluated in 14 patients with acromegaly following treatment with thyroid hormones. After an initial TRH test, seven patients received L-triiodothyronine, 100 mug daily for seven days; the GH response to TRH was not significantly altered by this treatment. Similar findings were noted in two acromegalic subjects who were tested with TRH before and after longer periods of administration of L-thyroxine. Four of five additional subjects with acromegaly who had received replacement doses of thyroid hormones for an average of 6.6 yr demonstrated GH responses to TRH which were similar to those seen in subjects not receiving thyroid hormones. Acute or long-term administration of replacement doses of thyroid hormones seems to have minimal effect on the GH response to TRH in acromegaly.
对14例肢端肥大症患者在接受甲状腺激素治疗后,评估其血清生长激素(GH)对促甲状腺激素释放激素(TRH)的反应。在首次TRH试验后,7例患者每日接受100μg的L-三碘甲状腺原氨酸,持续7天;该治疗对TRH的GH反应无明显改变。在两名肢端肥大症患者中,在长期给予L-甲状腺素前后进行TRH测试,也观察到类似结果。另外5例接受甲状腺激素替代剂量平均6.6年的肢端肥大症患者中,有4例对TRH的GH反应与未接受甲状腺激素的患者相似。急性或长期给予甲状腺激素替代剂量似乎对肢端肥大症患者对TRH的GH反应影响极小。